When a little known committee dismissed a complaint filed against a New Jersey Assemblywoman, it shined some rare sunlight on an industry raking in a healthy profit from marijuana prohibition: Substance abuse prevention and treatment centers.

The Joint Committee for Ethical Standards at the New Jersey Legislature on Tuesday dismissed a complaint filed against Assemblywoman Mary Pat Angelini (R. Monmouth) who had been accused of appearing to benefit from Garden State’s marijuana laws.

Gov. Chris Christie has been lauded in some circles for voicing support for new approaches to drug law offenders, mainly by putting some people into treatment instead of prison. But that political cover also keeps all drug prohibition laws (including those for marijuana) and penalties (including jail) fully intact.

The governor's new approach may also be growing a private industry that has little oversight. Businesses and nonprofits related to substance abuse and education (and have close ties to state agencies and elected officials) are more than happy to see people funneled out of the courts right to their front doors; bringing bags of tax dollars with them.

A law passed last year, Senate Bill 881, forces some of those arrested for drug offenses (including any amount of marijuana) into state-contracted (sometimes custodial) substance treatment programs. A judge must deem the offender to be "addicted" to cannabis. It started as a pilot program in northern N.J. It will cover the entire state in three years.

Angelini is the executive director of a non-profit called Prevention First, a company whose mission focuses on youth addiction and even violence issues. While Prevention First does not operate any substance treatment centers, they do provide the training and state certifications required for those who work within those facilities. Prevention First also facilitates directories of drug treatment facilities and options in Monmouth County. 

At the Joint Committee meeting there was a real question as to what Prevention First actually does; the Committee members and the staff attorney took a position that substance abuse treatment was wholly separate and distinct from substance abuse education or prevention.

The core issue in the complaint was if Assemblywoman Angelini was garnering a personal profit by voting against medical marijuana access, voting against decreasing penalties for adults caught with small amounts of cannabis and voting in favor of S881.

The Joint Committee entered into an interesting discussion, eventually acknowledging that substance abuse education, prevention and treatment were all part of the same "industry." They concluded that Angelini could express her opinion and vote on the bills because any benefit would be to her entire industry and not her non-profit specifically. The committee members compared it to a legislator who was a bank executive who sponsored and voted for bills favoring all financial institutions.

Because the committee opted to dismiss the complaint (based on the carefully crafted recommendation by their attorney) not even a cursory investigation took place that may have revealed a few more salient points.

With a budget of more than $1.8 million dollars per year, Prevention First is funded by cash grants supplied by the state of New Jersey, municipalities  and other government funds. Prevention First won grants from N.J. Department of Human Services and the Monmouth County Health and Human Services agency earmarked for  "mental health and addiction services." The organization lists fundraising collected and fundraising expenses as a financial wash (about $200,000) in their most recent annual report from 2011. One of the recent grants from New Jersey is for Prevention First to run one of seventeen official county coalitions for substance abuse prevention and treatment. On paper, the non-profit appears to be solely supported by tax-funded grants.

Prevention First spent more than $1 million in 2011 to pay their staff, consultants and professional service fees: $91,526 went to its executive director, Mary Pat Angelini, as salary. Angelini also pulls in a base salary of $49,000 from the state for her parttime gig as an assemblywoman.

The New Jersey Compassionate Use Medical Marijuana Act was signed into law back in 2010 but implementation of the extremely limited Medicinal Marijuana Program (MMP) has been significantly delayed. About 1,000 patients have registered with the MMP out of a patient population well over 300,000 statewide. The single Alternative Treatment Center allowed to start growing cannabis for those patients has now been closed for more than eight weeks.

Many residents with qualifying medical conditions use cannabis purchased in the underground marijuana market; sometimes they are arrested. Patients caught by police with underground marijuana in New Jersey (even those registered in the program with state-issued ID cards) are given no immunity by police or the court system. They are prosecuted and treated like any other offender.

Angelini is the singular public voice of absolute opposition to the compassionate use law. She has written numerous opinion pieces for newspapers and submitted many Letters to the Editor. When addressing the issue of medical cannabis in public forums, Angelini always uses her dual titles as an elected official and director of Prevention First.

There are more than 20,000 marijuana possession arrests each year in New Jersey; about half of all drug-related arrests in the state. Those arrested for marijuana are often given the option to complete substance abuse treatment/education programs - often at their own expense - as part of plea agreements with courts and prosecutors in exchange for lesser charges, reduced sentences and/or fines. Thus marijuana offenders are often required to seek out third party information about available treatment options to satisfy the courts.

Now some cannabis prohibition offenders (even if they are consuming it medicinally) can be remanded by judges into mandatory substance abuse treatment programs under Senate Bill 881.

SB 881 has also made more than $1 million in state money available (in the just the pilot phase) for "substance abuse" services at facilities certified and approved by the N.J. Department of Human Services.

Cannabis toxicity is low or non-existent and even the National Institute of Drug Abuse, a federal agency, rates its addictive qualities as less than caffeine and nicotine. When used as part of a medical therapy for serious illnesses, marijuana is not being used illicitly and its use by New Jersey residents should be outside of the concern of Prevention First or any other business in the addiction field.

Angelini and Prevention First have taken millions of dollars under the banner of substance abuse, showcasing just how easy it is for her industry to profit from drug prohibition offenders; mainly marijuana consumers. This money-making scheme, funded by taxpayers, is legal and institutionally ethical.

Philly420's Chris Goldstein smoked his first joint in 1994 and has been working to legalize marijuana ever since. He serves on the Board of Directors at PhillyNORML has been covering cannabis news for over a decade. Contact Goldstein at chris@freedomisgreen.com or on Twitter @freedomisgreen